Glenmark Pharmaceuticals Limited
No trades
Fundamentals and stats
EPS and revenue snapshot
In the last quarter, the company reported 14.28 INR per share, beating the 18.70 INR estimate by −23.64%. Revenue for the same period reached 39.01 B INR, despite the estimate of 38.33 B INR.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise